Shenyang Xingqi Pharmaceutical (300573.SZ) has obtained a drug registration certificate.
Xing Qi Eye Drops (300573.SZ) announcement, the company has received approval from the National Medical Products Administration for the issuance of Tefluprost...
Shenyang Xingqi Pharmaceutical (300573.SZ) announced that the company has received the Drug Registration Certificate for his fluorometholone eye drops issued by the National Medical Products Administration. This product is an eye drop mainly composed of fluorometholone, and the fluorometholone eye drops approved this time by the company are single-dose products without preservatives. The clinical indications include reducing elevated intraocular pressure in patients with open-angle glaucoma and high eye pressure.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
